Vlad Țâru (@vladtarumd) 's Twitter Profile
Vlad Țâru

@vladtarumd

ID: 1610670438220267522

calendar_today04-01-2023 16:12:42

25 Tweet

32 Followers

67 Following

Thomas Reiberger (@reibergerthomas) 's Twitter Profile Photo

#LiverTwitter 3 Relay Teams of the Vienna Liver News have finished 🥇🥈🥉 Vienna City Marathon #VCM2024 🏃🏻🏃🏻‍♂️ for #Liver #Disease Awareness

#LiverTwitter 
3 Relay Teams of the
<a href="/ViennaLiverNews/">Vienna Liver News</a> have finished 
🥇🥈🥉
Vienna City Marathon #VCM2024 

🏃🏻🏃🏻‍♂️ for #Liver #Disease Awareness
Thomas Reiberger (@reibergerthomas) 's Twitter Profile Photo

HEPEX Lab for #LiverFibrosis and #PortalHypertension MedUni Wien @t_sorz Digital Histomorphometry & AI @KathiBonitz Macrophage scSeq Benedikt Hofer ALD recompensation Vlad Țâru Inflammasome #ACLF Oleksandr Petrenko | opetrenko.bsky.social omics #PSC #ECMatrix

HEPEX Lab for #LiverFibrosis and #PortalHypertension <a href="/MedUni_Wien/">MedUni Wien</a> 

@t_sorz Digital Histomorphometry &amp; AI
@KathiBonitz Macrophage scSeq
<a href="/BenediktHofer/">Benedikt Hofer</a> ALD recompensation
<a href="/VladTaruMD/">Vlad Țâru</a> Inflammasome #ACLF
<a href="/xander_petrenko/">Oleksandr Petrenko | opetrenko.bsky.social</a> omics #PSC #ECMatrix
Vlad Țâru (@vladtarumd) 's Twitter Profile Photo

#inflammasomes The role of type 1 immune response via hepatic toll-like receptors (TLRs) & nucleotide-binding oligomerization domain-like (NLRs) : ♨️ inflammation ▶️ liver disease progression 💊 potential therapies Journal of Hepatology t.ly/JowDw

Thomas Reiberger (@reibergerthomas) 's Twitter Profile Photo

5Y evaluation of for our CD-Lab MedUni Wien & Boehringer Ingelheim for #PortalHypertension & #LiverFibrosis. 🗝️achievements: - investigation of #sGC signaling in liver disease - established #fibrosis #regression models - prognostic #biomarker - #scRNAseq in #PSC

5Y evaluation of for our CD-Lab 
<a href="/MedUni_Wien/">MedUni Wien</a> &amp; <a href="/Boehringer/">Boehringer Ingelheim</a> for
 #PortalHypertension &amp; #LiverFibrosis.

🗝️achievements:
- investigation of #sGC signaling in liver disease
- established #fibrosis #regression models
- prognostic #biomarker
- #scRNAseq in #PSC
The Baveno Cooperation: an EASL Consortium (@bavenocoop) 's Twitter Profile Photo

🎄 Wishing everyone a Merry Christmas and Happy Holidays from all of us at The Baveno Cooperation: an EASL Consortium ‼️ ✨ Here's to a joyful season and a 2025 filled with groundbreaking advancements for our patients—the heart of our profession 🧭🫂 👩‍🔬Thanks to all our colleagues for our shared mission‼️

Eur. Fdn. for the Study of Chronic Liver Failure (@ef_clif) 's Twitter Profile Photo

As we reflect on a year of collaboration and progress in understanding and treating #chronicliverdisease, we sincerely thank our partners and colleagues worldwide for their incredible support. Looking forward to a new year of discovery and impact!

MOTION Vienna (@crgmotion) 's Twitter Profile Photo

#twitterliver #PortalHypertension WP1 focuses on the classical & alternative renin-angiotensin system as a disease-driving mechanism in patients with compensated advanced chronic liver disease & investigates potentially beneficial effects of telmisartan in this patient group.⬇️⬇️

#twitterliver #PortalHypertension
WP1 focuses on the classical &amp; alternative renin-angiotensin system as a disease-driving mechanism in patients with compensated advanced chronic liver disease &amp; investigates potentially beneficial effects of telmisartan in this patient group.⬇️⬇️
Vlad Țâru (@vladtarumd) 's Twitter Profile Photo

Many thanks Vienna Liver News #LiverTwitter, exciting news! 🎉 My abstract has been accepted for #EASLCongress 2025 in Amsterdam, from 7-10 May. I hope to see you there – secure your spot now and let's revolutionise liver science together! 💡👩‍🔬 ctt.ec/PqUan+ EASLnews

The Baveno Cooperation: an EASL Consortium (@bavenocoop) 's Twitter Profile Photo

And last but not least... 💡Uncover the methodological pitfalls in observational studies in Hepatology. Ensure your research is robust and reliable‼️ ⏰ Just 1⃣ week to go! 🔗Register: baveno8.org/presymposium/ 🗓️March 5, 2025 💰Free for members | €100 non-members 👇

And last but not least...

💡Uncover the methodological pitfalls in observational studies in Hepatology. Ensure your research is robust and reliable‼️

⏰ Just 1⃣ week to go!

🔗Register: baveno8.org/presymposium/
🗓️March 5, 2025
💰Free for members | €100 non-members 👇
Vlad Țâru (@vladtarumd) 's Twitter Profile Photo

I am very thankful to the EASLnews for providing us with the opportunity to present our translational research on #NSBBs in #ACLF and to our amazing team Vienna Liver News for continuos support and motivation!

Mattias Mandorfer (@mattiasmandorf1) 's Twitter Profile Photo

The Baveno Cooperation: an EASL Consortium Research Committee Baveno VIII Pre-Symposium, here we go! 👍 103 members watching online 👉 High interest in designing clinical studies on PH! #LiverTwitter

<a href="/BavenoCoop/">The Baveno Cooperation: an EASL Consortium</a> Research Committee Baveno VIII Pre-Symposium, here we go!
👍 103 members watching online
👉 High interest in designing clinical studies on PH!
#LiverTwitter
EASLnews (@easlnews) 's Twitter Profile Photo

👩‍🔬👨‍🔬 Are you a young investigator at #EASLCongress 2025? Don’t miss the YI sessions designed just for you — including the must-attend workshop: “From Postdoc to PI” 🔬✨ Real stories, personal journeys, and honest discussions about the leap from postdoc to leading your own

EASLnews (@easlnews) 's Twitter Profile Photo

- 🌷🌷Final touches are underway as we get ready to welcome thousands of delegates to #EASLCongress 2025! From vibrant session spaces to a packed scientific programme, the RAI Amsterdam is set to become a true hub for hepatology. We can’t wait to open the doors and kick off

Salvatore Piano (@salvatore_piano) 's Twitter Profile Photo

📣New data on cirrhosis recompensation in Journal of Hepatology ✅Only 7% meets strict Baveno VII criteria ✅Expanded criteria capture ~38% with similar low mortality risk Recompensation: ⬇️systemic inflammation🔥 👍 improved hemodynamic ⬆️improved survival doi.org/10.1016/j.jhep…

📣New data on cirrhosis recompensation in <a href="/JHepatology/">Journal of Hepatology</a> 

✅Only 7% meets strict Baveno VII criteria
✅Expanded criteria capture ~38% with similar low mortality risk

Recompensation:
⬇️systemic inflammation🔥
👍 improved hemodynamic
⬆️improved survival

doi.org/10.1016/j.jhep…